Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
Roperch JP, Grandchamp B, Desgrandchamps F, Mongiat-Artus P, Ravery V, Ouzaid I, Roupret M, Phe V, Ciofu C, Tubach F, Cussenot O, Incitti R. Roperch JP, et al. Among authors: grandchamp b. BMC Cancer. 2016 Sep 1;16(1):704. doi: 10.1186/s12885-016-2748-5. BMC Cancer. 2016. PMID: 27586786 Free PMC article.
Sensitive allele-specific PCR assay able to detect FGFR3 mutations in tumors and urine from patients with urothelial cell carcinoma of the bladder.
Bakkar AA, Quach V, Le Borgne A, Toublanc M, Henin D, Wallerand H, Radvanyi F, Bittard H, Ravery V, Gibod LB, de Medina SG, Chopin DK, Grandchamp B. Bakkar AA, et al. Among authors: grandchamp b. Clin Chem. 2005 Aug;51(8):1555-7. doi: 10.1373/clinchem.2005.049619. Clin Chem. 2005. PMID: 16040860 No abstract available.
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
Cavé H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E. Cavé H, et al. Among authors: grandchamp b. N Engl J Med. 1998 Aug 27;339(9):591-8. doi: 10.1056/NEJM199808273390904. N Engl J Med. 1998. PMID: 9718378 Free article.
Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma.
Soufir N, Lacapere JJ, Bertrand G, Matichard E, Meziani R, Mirebeau D, Descamps V, Gérard B, Archimbaud A, Ollivaud L, Bouscarat F, Baccard M, Lanternier G, Saïag P, Lebbé C, Basset-Seguin N, Crickx B, Cave H, Grandchamp B. Soufir N, et al. Among authors: grandchamp b. Br J Cancer. 2004 Jan 26;90(2):503-9. doi: 10.1038/sj.bjc.6601503. Br J Cancer. 2004. PMID: 14735200 Free PMC article.
Association between endothelin receptor B nonsynonymous variants and melanoma risk.
Soufir N, Meziani R, Lacapère JJ, Bertrand G, Fumeron F, Bourillon A, Gérard B, Descamps V, Crickx B, Ollivaud L, Archimbaud A, Lebbe C, Basset-Seguin N, Saiag P, Grandchamp B; Investigators of the Melan-Cohort. Soufir N, et al. Among authors: grandchamp b. J Natl Cancer Inst. 2005 Sep 7;97(17):1297-301. doi: 10.1093/jnci/dji253. J Natl Cancer Inst. 2005. PMID: 16145050
260 results